IN THEIR POLICY FORUM "REGULATORY challenges in microbicide development" (25 June, p. 1911), P. M. Coplan et al. discuss the Food and Drug Administration's (FDA's) concern that use of HIV transmission-inhibiting microbicides in the future could decrease condom use and result in an increase in HIV transmission. Coplan et al. question this concern on the basis of a mathematical modeling study by Foss et al. indicating that a partially efficacious microbicide could undermine the benefit only in settings where condoms are used in more than 70% of coital acts (1) . This "threshold" has also been quoted in various microbicide meetings; however, the validity of this view depends on intrinsic assumptions of microbicide efficacy and use.
We wish to stress that condom abandonment in favor of microbicides could only be a problem if the efficacies of the introduced microbicides are substantially less than the efficacy of condoms. If microbicide efficacy is similar to condom efficacy, then replacement of one protection option (condoms) by another protection option (microbicides) will not increase HIV transmission rates. Thus, the central focus of discussions should be on the efficacy of microbicides.
Current condom usage is generally much less than the level that would yield a negative outcome if condoms were abandoned in favor of reasonably efficacious microbicides [especially in the developing world, where only approximately 1% of sexually active women report condom use in the past month (2)]. We support the point made by Coplan et al. that the FDA concerns are unwarranted, especially in resource-constrained countries. We emphasize, however, that discussion of any threshold condom usage should be qualified by the appropriate assumptions, and, more importantly, the discussion should address the efficacy of microbicides.
WE WOULD LIKE TO ADD SOME COMMENTS TO the excellent and long-overdue Policy Forum "Regulating challenges in microbicide development" by P. M. Coplan et al. (25 June, p. 1911 ). The U.S. National Institutes of Health is at present sponsoring a large microbicide trial. In addition to the necessary putative microbicides being tested and the placebo, this trial has an open arm, namely, "condom only" or "no gel." NIH has been severely criticized both in print (1) and at open hearings (2) for taking this step. In controlled trials, the double-blinding rule aims to ensure that differences between intervention and control arms are inapparent to both subjects and researchers. Any "open arm" violates this rule and threatens the integrity of the findings; in unmeasurable ways, it may modify both the administration of treatment and the response of subjects to that treatment. Moreover, adding an arm with numbers (already very large) to equal those of either the treatment under test or the placebo cannot but entail more effort, time, and costs in executing a trial. The figure in Coplan et al. ' s Policy Forum clearly illustrates that imperviousness to criticism on this point results in tragic delay. Delay is unacceptable in a world that needs a microbicide and needs it with great urgency.
Also, we pose a question for consideration by institutional review boards and ethicists: Is it not unethical to authorize a study that recruits more than 800 women as volunteers to a study arm that cannot be expected to yield scientifically useful information? The FDA has stated that vaginal microbicide programs that demonstrate safety and efficacy in protecting against HIV infection in placebo-controlled, randomized trials may not receive licensure approval unless the randomized trials demonstrate significantly greater efficacy than both a placebo-controlled blinded arm and an unblinded "condom only" or "no gel" arm (2). We must seriously consider not only the relevance but the ethics of insisting that microbicide pivotal efficacy trials show statistically significant benefits against an unblinded "no gel" arm, when thousands of women are being infected with HIV daily. 
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LETTERS
Is it not unethical to authorize a study that recruits more than 800 women as volunteers to a study arm that cannot be expected to yield scientifically useful information?" Oct., p. 595). However, those scientists and scientific organizations making these accusations do not seem to be applying the same rigor to their accusations that they do to their own research. Eighty percent of the award applicants were male. If the review process were completely gender-blind and there were no gender differences in the quality of proposals, the possibility that all nine awardees would be male is 13%. Presumably, those accusing NIH of gender bias do not reject null models in their own research with comparable P values. Why should they be so quick to reject it here? It is likely that historical gender bias throughout the scientific community is partly responsible for the low proportion of award applications by women. However, the data do not justify accusations of gender bias against NIH in this case. 
Nuclear Material Loopholes

READERS OF SCIENCE SHOULD BE GRATEFUL TO L. Palmer and G. Milhollin for describing
Brazil's intention to operate a new uranium enrichment plant, and the proliferation concerns this action arouses ("Brazil's nuclear puzzle," Policy Forum, 22 Oct., p. 617). If apprehension about global warming causes an expansion of nuclear power deployment during the next half century (1), it is vital to limit the spread of dangerous fuel cycle activities-enrichment and reprocessing-that can lead to nuclear weapons. Palmer and Milhollin suggest that if Brazil cooperates with International Atomic Energy Agency (IAEA) inspections and presumably accepts the "additional protocol" for challenge inspections, Brazil will be a "good nuclear citizen," and the United States and the rest of the world should accept Brazil's enrichment activity.
We disagree. As we (2), and others, have argued, the proper policy is to avoid all new enrichment and reprocessing activity in non-nuclear weapons states and for nuclear supplier states to provide recipient states with internationally assured enrichment and spent fuel disposal services at attractive prices. This would begin with a "stay-put" period of 10 to 15 years, after which nations could reevaluate in light of nuclear power and nonproliferation developments.
We should not adopt a policy toward Brazil that we are unwilling to accept for Iran and North Korea. The latter have brought to a head the shortcomings of the Nuclear Nonproliferation Treaty (NPT) implementation regime-these states employ the regime to move to the brink of a weapons capability within the treaty framework. Closing NPT loopholes needs urgent attention, and Brazil will jeapordize the possibilities for successful resolution if they move forward with their uranium enrichment plant. The argument that Brazil is not seeking a weapons capability has not always been true, and IAEA inspections are not an adequate safeguard against states that are seeking nuclear capability, such as Iran and North Korea. IAEA inspections are not sufficient for controlling the spread of nuclear weapons capability, and the United States will not be successful with a policy based on a chosen few-the United States and other nuclear weapons states-deciding which other nations can safely develop fuel cycle activities and which cannot. The United States should vigorously oppose the Brazilian enrichment plant and offer Brazil concrete incentives to abandon this dangerous course of action. Brazil faces a choice of being a spoiler in modernizing the NPT implementation regime or of being a leader in accomplishing that important end.
Response
IN OUR OPINION, CULLING IS NOT "A PRIMARY component" of ecosystem-based fishery management (EBFM).
The key point of our Policy Forum is that EBFM reverses the order of management priorities so that the objective of sustaining ecosystem structure and function supersedes the objective of maximizing fisheries yields. Achieving this might involve selectively harvesting and protecting different parts of the ecosystem at different times-for example, protecting depleted populations and habitats, harvesting target populations with an intensity related to their recent productivity, and targeted removal of invasive species or species greatly favored by anthropogenic activities such as fishing and pollution. Therefore, EBFM does not preclude culling to achieve the objective of healthy ecosystems, provided that it would not cause harm to the structure and function of the ecosystem and would be undertaken in an adaptive, precautionary manner. On the other hand, our interpretation of EBFM is not supportive of large reductions in the natural levels of native populations or ecosystem elements to enhance fisheries yields or with intentionally depleting predators to help compensate for fishery overharvesting of prey species. Furthermore, because marine ecosystems are highly complex, variable, and difficult to predict, attempts to manipulate the ecosystem to enhance commercial fishery yield might not produce the intended consequence and may further degrade the ecosystem.
We believe EBFM is a new, better and all-encompassing way to manage marine fisheries, and it would be unhelpful if the debate were to be overshadowed by a tangential issue such as culling. 
CORRECTIONS AND CLARIFICATIONS:
Perspectives: The Godfrey Perspective in the 3 December issue (p. 1687) was incorrectly marked as having been enhanced. The Kargel Perspective (p. 1689) was in fact enhanced.
Special Issue on Genes in Action: "Solving gene expression" by B. R. Jasny and L. Roberts (22 Oct., p. 629). In the second paragraph, Elaine Alarid's name was mistakenly spelled as Alaric.
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it takes both sides of the brain.
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Science &Engineering Visualization Challenge
Accept the challenge. Show how you'vemastered the art of understanding.
When the left brain collaborates with the right brain, science merges with art to enhance communication and understanding of research results-illustrating concepts,d epicting phenomena, drawing conclusions.
The National Science Foundation and Science, publishedb y the 
